Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients [NA]

View source ↗

Summary

A clinical trial evaluating an enzymatic mouth spray (Oral7) for xerostomia in older adults, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral7

Snippet

Sponsor: ZAINAB MAT YUDIN | Conditions: Xerostomia, Geriatric | NA | Status: NOT_YET_RECRUITING